Patent 7405061 was granted and assigned to Raven Biotechnologies on July, 2008 by the United States Patent and Trademark Office.
Provided herein is disclosure about the identification and characterization of disease and cancer associated antigen PIPA. The invention also provides a family of monoclonal antibodies that bind to antigen PIPA, and methods of diagnosing and treating various human cancers and diseases that express PIPA.